Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolocumab Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study

NCT02957604 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02957604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02957604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolocumab Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study
Lead sponsor
Amgen
Phase
Observational
Overall status
Terminated
Start date
December 22, 2016
Completion date
September 2, 2020
Enrollment
140 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia; ascvd; pregnancy